The virus as metabolic engineer

Biotechnology Journal

Volumn 5, Issue 7, 2010, Pages 686-694

  Maynard, Nathaniel D ^a   Gutschow, Miriam V ^a   Birch, Elsa W ^a   Covert, Markus W ^a  

^a Stanford University   (United States)

Author keywords

Metabolic engineering; Systems biology; Virology

Indexed keywords

ENGINEERING; ENGINEERS; MICROBIOLOGY; VIRUSES;

METABOLIC ENGINEERING; VIRAL INFECTIONS; VIRAL PARTICLES; WIDE SCREEN;

METABOLISM;

ADENOSINE TRIPHOSPHATE; CITRIC ACID; NUCLEOTIDE; POLYLACTIC ACID; RIBONUCLEASE; VIRUS RNA;

BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL METABOLISM; BACTERIAL STRAIN; BACTERIOPHAGE; BACTERIOPHAGE LAMBDA; BIOMASS; BIOSYNTHESIS; CYTOMEGALOVIRUS; DENGUE VIRUS; ESCHERICHIA COLI; FELINE LEUKEMIA VIRUS; GENE EXPRESSION; GLYCOLYSIS; INFLUENZA VIRUS; METABOLIC ENGINEERING; METABOLISM; MS2 VIRUS; MUTAGENESIS; PENTOSE PHOSPHATE CYCLE; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; REVIEW; ROUS SARCOMA ONCOVIRUS; RUBELLA; VESICULAR STOMATITIS VIRUS; VIRION; VIRUS; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS REPLICATION; WEST NILE FLAVIVIRUS; GENETIC ENGINEERING; HUMAN; PROCEDURES; VIRUS DISEASES; VIRUS GENE;

GENES, VIRAL; GENETIC ENGINEERING; HUMANS; VIRUS DISEASES; VIRUSES;

EID: 77954743469     PISSN: 18606768     EISSN: 18607314     Source Type: Journal    
DOI: 10.1002/biot.201000080     Document Type: Review

References (89)

1. Mathers, C., Boerma, T., Ma Fat, D., The global burden of disease: 2004 update, vii, World Health Organization, Geneva 2008, p. 146.
2. Thayer, A., Genzyme signs consent decree With U. S. Chem. Eng. News 2010, 88, 33.
3. Sawyer, L. A., Antibodies for the prevention and treatment of viral diseases. Antiviral Res. 2000, 47, 57-77.
4. Dykxhoorn, D. M., Lieberman, J., Silencing viral infection. PLoS Med. 2006, 3, e242.
5. Park, S. J., Cochran, J. R., Protein Engineering and Design. Taylor and Francis, Boca Raton 2009.
6. Sharan, S. K., Thomason, L. C., Kuznetsov, S. G., Court, D. L., Recombineering: a homologous recombination-based meth od of genetic engineering. Nat. Protoc. 2009, 4, 206-223.
7. Lois, C., Hong, E. J., Pease, S., Brown, E. J., Baltimore, D., Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 2002, 295, 868-872.
8. Yin, J., Chemical engineering and virology: Challenges and opportunities at the interface. Aiche J. 2007, 53, 2202-2209.
9. Vaheri, A., Cristofalo, V. J., Metabolism of rubella virus-infected BHK 21 cells. Enhanced glycolysis and late cellular inhibition. Arch. Gesamte Virusforsch. 1967, 21, 425-436.
10. Singh, V. N., Singh M., August, J. T., Horecker, B. L., Alterations in glucose metabolism in chick-embryo cells transformed by Rous sarcoma virus: Intracellular levels of glycolytic intermediates. Proc. Natl. Acad. Sci. USA 1974, 71, 4129-4132.
11. Bardell, D., Essex, M., Glycolysis during early infection of feline and human cells with feline leukemia virus. Infect. Immun. 1974, 9, 824-827.
12. Levy, H. B., Baron, S., The effect of animal viruses on host cell metabolism. II. Effect of poliomyelitis virus on glycolysis and uptake of glycine by monkey kidney tissue cultures. J. Infect. Dis. 1957, 100, 109-118.
13. Green, M., Henle, G., Deinhardt, F., Respiration and glycolysis of human cells grown in tissue culture. Virology 1958, 5, 206-219.
14. Fisher, T. N., Ginsberg, H. S., The reaction of influenza viruses with guinea pig polymorphonuclear leucocytes. II. The reduction of white blood cell glycolysis by influenza viruses and receptor-destroying enzyme (RDE). Virology 1956, 2, 637-655.
15. Klemperer, H., Glucose breakdown in chick embryo cells infected with influenza virus. Virology 1961, 13, 68-77.
16. Salzman, N. P., Lockart, R. Z. Jr., Sebring, E. D., Alterations in HeLa cell metabolism resulting from poliovirus infection. Virology 1959, 9, 244-259.
17. Bardeletti, G., Respiration and ATP level in BHK21/13S cells during the earlist stages of rubella virus replication. Intervirology 1977, 8, 100-109. (Pubitemid 8068973)
18. Gaitskhoki, V. S., Ershov, F. I., Kiselev, O. I., Men'shikh, L. K., Zaitseva, O. V., Reconstruction of autonomic genetic and protein-synthesizing systems from viral RNA and isolated mitochondria. Dokl. Akad. Nauk. SSSR 1971, 201, 220-223.
19. Burgener, A., Coombs, K., Butler, M., Intracellular ATP and total adenylate concentrations are critical predictors of reovirus productivity from Vero cells. Biotechnol. Bioeng. 2006, 94, 667-679.
20. El-Bacha, T., Midlej, V., Pereira da Silva, A. P., Silva da Costa, L. et al., Mitochondrial and bioenergetic dysfunction in human hepatic cells infected with dengue 2 virus. Biochim. Biophys. Acta 2007, 1772, 1158-1166.
21. El-Bacha, T., Menezes, M. M., Azevedo e Silva, M. C., Sola-Penna, M., Da Poian, A. T., Mayaro virus infection alters glucose metabolism in cultured cells through activation of the enzyme 6-phosphofructo 1-kinase. Mol. Cell. Biochem. 2004, 266, 191-198.
22. Munger, J., Bajad, S. U., Coller, H. A., Shenk, T. et al., Dynamics of the cellular metabolome during human cytomegalovirus infection. PLoS Pathog. 2006, 2, e132.
23. Munger, J., Bennett, B. D., Parikh, A., Feng, X.-J. et al., Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy. Nat. Biotechnol. 2008, 26, 1179-1186.
24. Baba, T., Ara, T., Hasegawa, M., Takai, Y. et al., Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol. Syst. Biol. 2006, 2, 2006 0008.
25. Winzeler, E. A., Shoemaker, D. D., Astromoff, A., Liang, H. et al., Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science 1999, 285, 901-906.
26. Brass, A. L., Dykxhoorn, D. M., Benita, Y., Yan, N. et al., Identification of host proteins required for HIV infection through a functional genomic screen. Science 2008, 319, 921-926.
27. Konig, R., Zhou, Y., Elleder, D., Diamond, T. L. et al., Global analysis of host-pathogen interactions that regulate earlystage HIV-1 replication. Cell 2008, 135, 49-60.
28. Rato, S., Maia, S., Brito, P. M., Resende, L. et al., Novel HIV-1 knockdown targets identified by an enriched kinases/phosphatases shRNA library using a long-term iterative screen in Jurkat T-cells. PLoS One 2010, 5, e9276.
29. Zhou, H., Xu, M., Huang, Q., Gates, A. T. et al., Genomescale RNAi screen for host factors required for HIV replication. Cell Host Microbe 2008, 4, 495-504.
30. Brass, A. L., Huang, I. C., Benita, Y., John, S. P. et al., The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 2009, 139, 1243-1254.
31. Hao, L., Sakurai, A., Watanabe, T., Sorensen, E. et al., Drosophila RNAi screen identifies host genes important for influenza virus replication. Nature 2008, 454, 890-893.
32. Karlas, A., Machuy, N., Shin, Y., Pleissner, K. P. et al., Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature 2010, 463, 818-822.
33. Konig, R., Stertz, S., Zhou, Y., Inoue, A. et al., Human host factors required for influenza virus replication. Nature 2010, 463, 813-817.
34. Shapira, S. D., Gat-Viks, I., Shum, B. O., Dricot, A. et al., A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell 2009, 139, 1255-1267.
35. Krishnan, M. N., Ng, A., Sukumaran, B., Gilfoy, F. D. et al., RNA interference screen for human genes associated with West Nile virus infection. Nature 2008, 455, 242-245.
36. Sessions, O. M., Barrows, N. J., Souza-Neto, J. A., Robinson, T. J. et al., Discovery of insect and human dengue virus host factors. Nature 2009, 458, 1047-1050.
37. Cherry, S., Doukas, T., Armknecht, S., Whelan, S. et al., Genome-wide RNAi screen reveals a specific sensitivity of IRES-containing RNA viruses to host translation inhibition. Genes Dev. 2005, 19, 445-452.
38. Li, Q., Brass, A. L., Ng, A., Hu, Z. et al., A genome-wide genetic screen for host factors required for hepatitis C virus propagation. Proc. Natl. Acad. Sci. USA 2009, 106, 16410-16415.
39. Tai, A. W., Benita, Y., Peng, L. F., Kim, S. S. et al., A functional genomic screen identifies cellular cofactors of hepatitis C virus replication. Cell Host Microbe 2009, 5, 298-307.
40. An, P., Winkler, C. A., Host genes associated with HIV/AIDS: advances in gene discovery. Trends Genet. 2010, 26, 119-131.
41. Arhel, N., Kirchhoff, F., Host proteins involved in HIV infection: New therapeutic targets. Biochim. Biophys. Acta 2010, 1802, 313-321.
42. Bushman, F. D., Malani, N., Fernandes, J., D'Orso, I. et al., Host cell factors in HIV replication: Meta-analysis of genome-wide studies. PLoS Pathog. 2009, 5, e1000437.
43. Goff, S. P., Knockdown screens to knockout HIV-1. Cell 2008, 135, 417-420.
44. Kok, K. H., Lei, T., Jin, D. Y., siRNA and shRNA screens advance key understanding of host factors required for HIV-1 replication. Retrovirology 2009, 6, 78.
45. Min, J. Y., Subbarao, K., Cellular targets for influenza drugs. Nat. Biotechnol. 2010, 28, 239-240.
46. Borner, K., Hermle, J., Sommer, C., Brown, N. P. et al., From experimental setup to bioinformatics: An RNAi screening platform to identify host factors involved in HIV-1 replication. Biotechnol. J. 2010, 5, 39-49.
47. Sharma, S., Rao, A., RNAi screening: tips and techniques. Nat. Immunol. 2009, 10, 799-804.
48. Zhang, X. D., Heyse, J. F., Determination of sample size in genome-scale RNAi screens. Bioinformatics 2009, 25, 841-844.
49. Zhang, X. D., Marine, S. D., Ferrer, M., Error rates and powers in genome-scale RNAi screens. J. Biomol. Screen 2009, 14, 230-238.
50. Tomizawa, J., Ogawa, T., Effect of ultraviolet irradiation on bacteriophage lambda immunity. J. Mol. Biol. 1967, 23, 247-263.
51. Fischer, E., Zamboni, N., Sauer, U., High-throughput metabolic flux analysis based on gas chromatography-mass spectrometry derived 13C constraints. Anal. Biochem. 2004, 325, 308-316.
52. Sauer, U., High-throughput phenomics: experimental methods for mapping fluxomes. Curr. Opin. Biotechnol. 2004, 15, 58-63.
53. Yus, E., Maier, T., Michalodimitrakis, K., van Noort, V. et al., Impact of genome reduction on bacterial metabolism and its regulation. Science 2009, 326, 1263-1268.
54. Ishii, N., Nakahigashi, K., Baba, T., Robert, M. et al., Multiple high-throughput analyses monitor the response of E. coli to perturbations. Science 2007, 316, 593-597.
55. Keasling, J. D., Gene-expression tools for the metabolic engineering of bacteria. Trends Biotechnol. 1999, 17, 452-460.
56. Reich, J. G., Selkov, E. E., Energy metabolism of the cell: A theoretical treatise, viii, Academic Press, New York 1981, p 345.
57. Stephanopoulos, G., Aristidou, A. A., Nielsen, J. H., Metabolic engineering: Principles and Methodologies, xxi, Academic Press, San Diego 1998, p. 725.
58. Westerhoff, H. V., Palsson, B. O., The evolution of molecular biology into systems biology. Nat. Biotechnol. 2004, 22, 1249-1252.
59. Varma, A., Palsson, B. O., Stoichiometric flux balance models quantitatively predict growth and metabolic by-product secretion in wild-type Escherichia coli W3110. Appl. Environ. Microbiol. 1994, 60, 3724-3731.
60. Price, N. D., Papin, J. A., Schilling, C. H., Palsson, B. O., Genome-scale microbial in silico models: the constraints-based approach. Trends Biotechnol. 2003, 21, 162-169.
61. Blazeck, J., Alper, H., Systems metabolic engineering: Genome-scale models and beyond. Biotechnol. J. 2010, in press. DOI: 10.1002/biot.200900274.
62. Park, J. H., Lee, S. Y., Kim, T. Y., Kim, H. U., Application of systems biology for bioprocess development. Trends Biotechnol. 2008, 26, 404-412.
63. Yang, T. H., Kim, T. W., Kang, H. O., Lee, S. H. et al., Biosynthesis of polylactic acid and its copolymers using evolved propionate CoA transferase and PHA synthase. Biotechnol. Bioeng. 2010, 105, 150-160.
64. Jung, Y. K., Kim, T. Y., Park, S. J., Lee, S. Y., Metabolic engineering of Escherichia coli for the production of polylactic acid and its copolymers. Biotechnol. Bioeng. 2010, 105, 161-171.
65. Carothers, J. M., Goler, J. A., Keasling, J. D., Chemical synthesis using synthetic biology. Curr. Opin. Biotechnol. 2009, 20, 498-503.
66. Lee, S. K., Chou, H., Ham, T. S., Lee, T. S., Keasling, J. D., Metabolic engineering of microorganisms for biofuels production: from bugs to synthetic biology to fuels. Curr. Opin. Biotechnol. 2008, 19, 556-563.
67. Park, J. H., Lee, K. H., Kim, T. Y., Lee, S. Y., Metabolic engineering of Escherichia coli for the production of L-valine based on transcriptome analysis and in silico gene knockout simulation. Proc. Natl. Acad. Sci. USA 2007, 104, 7797-7802.
68. Syed, G. H., Amako, Y., Siddiqui, A., Hepatitis C virus hijacks host lipid metabolism. Trends Endocrinol. Metab. 2010, 21, 33-40.
69. Ikeda, M., Kato, N., Modulation of host metabolism as a target of new antivirals. Adv. Drug Deliv. Rev. 2007, 59, 1277-1289.
70. Sidorenko, Y., Reichl, U., Structured model of influenza virus replication in MDCK cells. Biotechnol. Bioeng. 2004, 88, 1-14.
71. Ellner, S. P., Guckenheimer, J., Dynamic models in biology, xxii, Princeton University Press, Princeton 2006, p. 329.
72. Knorr, A. L., Srivastava, R., Evaluation of HIV-1 kinetic models using quantitative discrimination analysis. Bioinformatics 2005, 21, 1668-1677.
73. Pearl, S., Gabay, C., Kishony, R., Oppenheim, A., Balaban, N. Q., Nongenetic individuality in the host-phage interaction. PLoS Biol. 2008, 6, e120.
74. Maynard, N. D., Birch, E. B., Sanghri, J. C., Chen, L. et al., A forward-genetic screen and dynamic analysis of lambda phage host-dependencies reveals an extensive interaction network and a new anti-viral strategy. Plos Genetics 2010, in press.
75. Endy, D., Kong, D., Yin, J., Intracellular kinetics of a growing virus: A genetically structured simulation for bacteriophage T7. Biotechnol. Bioeng. 1997, 55, 375-389.
76. Arkin, A., Ross, J., McAdams, H. H., Stochastic kinetic analysis of developmental pathway bifurcation in phage lambda-infected Escherichia coli cells. Genetics 1998, 149, 1633-1648. (Pubitemid 28375939)
77. Hensel, S. C., Rawlings, J. B., Yin, J., Stochastic kinetic modeling of vesicular stomatitis virus intracellular growth. Bull. Math. Biol. 2009, 71, 1671-1692.
78. Feist, A. M., Henry, C. S., Reed, J. L., Krummenacker, M. et al., A genome-scale metabolic reconstruction for Escherichia coli K-12 MG1655 that accounts for 1260 ORFs and thermodynamic information. Mol. Syst. Biol. 2007, 3, 121.
79. Covert, M. W., Knight, E. M., Reed, J. L., Herrgard, M. J., Palsson, B. O., Integrating high-throughput and computational data elucidates bacterial networks. Nature 2004, 429, 92-96.
80. Jain, R., Srivastava, R., Metabolic investigation of host/pathogen interaction using MS2-infected Escherichia coli. BMC Syst. Biol. 2009, 3, 121.
81. Thiele, I., Palsson, B. O., A protocol for generating a highquality genome-scale metabolic reconstruction. Nat. Protoc. 2010, 5, 93-121.
82. Burgard, A. P., Pharkya, P., Maranas, C. D., Optknock: a bilevel programming framework for identifying gene knockout strategies for microbial strain optimization. Biotechnol. Bioeng. 2003, 84, 647-657.
83. Tepper, N., Shlomi, T., Predicting metabolic engineering knockout strategies for chemical production: accounting for competing pathways. Bioinformatics 2010, 26, 536-543.
84. Duarte, N. C., Becker, S. A., Jamshidi, N., Thiele, I. et al., Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc. Natl. Acad. Sci. USA 2007, 104, 1777-1782.
85. Mahadevan, R., Edwards, J. S., Doyle, F. J. 3rd, Dynamic flux balance analysis of diauxic growth in Escherichia coli. Biophys. J. 2002, 83, 1331-1340.
86. Thomas, R., Boolean formalization of genetic control circuits. J. Theor. Biol. 1973, 42, 563-585.
87. Covert, M. W., Schilling, C. H., Palsson, B., Regulation of gene expression in flux balance models of metabolism. J. Theor. Biol. 2001, 213, 73-88.
88. Kremling, A., Bettenbrock, K., Gilles, E. D., Analysis of global control of Escherichia coli carbohydrate uptake. BMC Syst. Biol. 2007, 1, 42.
89. Covert, M. W., Xiao, N., Chen, T. J., Karr, J. R., Integrating metabolic, transcriptional regulatory and signal transduction models in Escherichia coli. Bioinformatics 2008, 24, 2044-2050.